nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of lung cancer and hypercoagulability, complicated by suspected heparin-induced thrombocytopenia
|
Konala, Venu Madhav |
|
2011 |
|
5 |
p. 233-236 4 p. |
artikel |
2 |
Adding bevacizumab to our protocols has improved patient outcomes with little added risk
|
Hartman, Andrea |
|
2007 |
|
5 |
p. 298- 1 p. |
artikel |
3 |
An EMR story
|
Henry, David H. |
|
2007 |
|
5 |
p. 313- 1 p. |
artikel |
4 |
A new asparaginase option for ALL
|
Atallah, Ehab |
|
2012 |
|
5 |
p. 145- 1 p. |
artikel |
5 |
Angiogenic inhibitors: a fourth modality of anticancer therapy
|
Folkman, Judah |
|
2007 |
|
5 |
p. 296-298 3 p. |
artikel |
6 |
A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer
|
Mani, Aruna |
|
2011 |
|
5 |
p. 209-215 7 p. |
artikel |
7 |
A plea for new coding
|
Neltner, Martin E. |
|
2010 |
|
5 |
p. 229-231 3 p. |
artikel |
8 |
Ask your lawyer
|
Doty, Lee W. |
|
2006 |
|
5 |
p. 289-290 2 p. |
artikel |
9 |
Better communication with minority patients: seven strategies for achieving cultural competency
|
Patten Jr., Carl W. |
|
2006 |
|
5 |
p. 295-299 5 p. |
artikel |
10 |
Better margins, better quality: seizing the moment
|
Gosfield, Alice G. |
|
2005 |
|
5 |
p. 441-444 4 p. |
artikel |
11 |
Bevacizumab: antiangiogenesis success story
|
Abraham, Jame |
|
2007 |
|
5 |
p. 290-292 3 p. |
artikel |
12 |
Bevacizumab's role in treating advanced colorectal cancer
|
Jones, Matthew P. |
|
2007 |
|
5 |
p. 295-296 2 p. |
artikel |
13 |
Board-certified oncology pharmacists: partners in the multidisciplinary care of cancer patients
|
Stull, Dawn Marie |
|
2006 |
|
5 |
p. 284-286 3 p. |
artikel |
14 |
Brain metastasis from non-small cell lung cancer: sustained response with erlotinib
|
Velagapudi, Venu |
|
2009 |
|
5 |
p. 203-204 2 p. |
artikel |
15 |
CAP is not the answer
|
Okon, Ted |
|
2005 |
|
5 |
p. 454-455 2 p. |
artikel |
16 |
Choosing, installing, and supporting an EMR system
|
Tarr, Peter J. |
|
2007 |
|
5 |
p. 316-318 3 p. |
artikel |
17 |
Clinical and administrative issues: keeping current, changing hats
|
Schwartzberg, Lee S. |
|
2007 |
|
5 |
p. 270- 1 p. |
artikel |
18 |
Clinical trial awareness, attitudes, and participation among patients with cancer and oncologists
|
Fenton, Laurie |
|
2009 |
|
5 |
p. 207-213 7 p. |
artikel |
19 |
Combining sorafenib with chemoembolization for hepatocellular cancer
|
Choi, Minsig |
|
2011 |
|
5 |
p. 216-219 4 p. |
artikel |
20 |
Community experience
|
Balalian, Steve |
|
2005 |
|
5 |
p. 438-439 2 p. |
artikel |
21 |
Counseling patients on pregnancy after breast cancer: arming yourself with the facts
|
Bosserman, Linda D. |
|
2007 |
|
5 |
p. 347-348 2 p. |
artikel |
22 |
Creating a community-based, patient-centered cancer survivorship program
|
Fisher, Robert E. |
|
2012 |
|
5 |
p. 171-173 3 p. |
artikel |
23 |
Crossing the digital Rubicon: committing to electronic medical record systems
|
Tarr, Peter J. |
|
2007 |
|
5 |
p. 311-314 4 p. |
artikel |
24 |
Degarelix, a new GnRH antagonist, in prostate cancer
|
Abraham, Jame |
|
2009 |
|
5 |
p. 197-199 3 p. |
artikel |
25 |
Degarelix: medical castration without fare
|
Gulley, James L. |
|
2009 |
|
5 |
p. 199-200 2 p. |
artikel |
26 |
Detecting asymptomatic endometrial carcinoma by combined PET/CT
|
English, Cynthia A. |
|
2006 |
|
5 |
p. 246- 1 p. |
artikel |
27 |
Developing a hazardous drug safe-handling program
|
Polovich, Martha |
|
2005 |
|
5 |
p. 403-405 3 p. |
artikel |
28 |
Doing well by doing good
|
Schwartzberg, Lee S. |
|
2005 |
|
5 |
p. 375- 1 p. |
artikel |
29 |
Duodenal somatostatinoma and gastrointestinal stromal tumor associated with neurofibromatosis
|
Sullivan, Susan Kruse |
|
2006 |
|
5 |
p. 266-270 5 p. |
artikel |
30 |
Emotional distress in patients with cancer: the sixth vital sign
|
Bultz, Barry D. |
|
2006 |
|
5 |
p. 311-314 4 p. |
artikel |
31 |
Emperipolesis in giant cell carcinoma of the lung
|
Usmani, Saad Z. |
|
2010 |
|
5 |
p. 233-235 3 p. |
artikel |
32 |
Endometrial adenocarcinoma with idiopathic thrombocytopenic purpura treated without chemotherapy or irradiation
|
Nojima, Tomoko |
|
2008 |
|
5 |
p. 258-260 3 p. |
artikel |
33 |
Erwinia asparaginase for acute lymphoblastic leukemia in children with hypersensitivity to E coli-derived asparaginase
|
Abraham, Jame |
|
2012 |
|
5 |
p. 146-147 2 p. |
artikel |
34 |
Estimation of the incidence of febrile neutropenia in women receiving docetaxel plus cyclophosphamide as adjuvant therapy for early-stage breast cancer: a large community-based retrospective study
|
Bordoni, Rodolfo Eduardo |
|
2012 |
|
5 |
p. 158-164 7 p. |
artikel |
35 |
Evaluating adjuvant hormonal therapy in early-stage breast cancer: a comparison of predictive decision models
|
Rivera, Edgardo |
|
2007 |
|
5 |
p. 277-282 6 p. |
artikel |
36 |
Facing reality: cancer clinics and the full impact of MMA
|
Coplon, Steven M. |
|
2006 |
|
5 |
p. 317-318 2 p. |
artikel |
37 |
Feeding your software-hungry PDA
|
Fried, John J. |
|
2006 |
|
5 |
p. 301-302 2 p. |
artikel |
38 |
Fertility and breast cancer: the issues
|
Theriault, Richard L. |
|
2007 |
|
5 |
p. 337-338 2 p. |
artikel |
39 |
Finding programs to help patients pay for drugs is now much easier
|
Vanchieri, Cori |
|
2005 |
|
5 |
p. 410- 1 p. |
artikel |
40 |
First-year EMR check-up
|
|
|
2007 |
|
5 |
p. 322- 1 p. |
artikel |
41 |
For CMS, The definition of ‘meaningful’
|
Young, Patrick |
|
2010 |
|
5 |
p. 240- 1 p. |
artikel |
42 |
Health-resource utilization attributable to skeletal-related events in patients with advanced cancers associated with bone metastases: results of the US cohort from a multicenter observational study
|
Mahmood, Aftab |
|
2012 |
|
5 |
p. 148-157 10 p. |
artikel |
43 |
Hydroxyurea-induced palmar-plantar erythrodysesthesia in an adult with sickle cell disease
|
Bambrah, Ramandeep K. |
|
2011 |
|
5 |
p. 237-238 2 p. |
artikel |
44 |
Identifying and reporting adverse drug events in oncology
|
Hong, Aleta J. |
|
2008 |
|
5 |
p. 255-256 2 p. |
artikel |
45 |
I hear a voice: using speech recognition systems in community practice
|
Fried, John J. |
|
2007 |
|
5 |
p. 326- 1 p. |
artikel |
46 |
Implementation of sentinel node biopsy for breast cancer in a community hospital
|
Avisar, Eli |
|
2008 |
|
5 |
p. 271-273 3 p. |
artikel |
47 |
Importance of molecular confirmation in the diagnosis of myeloproliferative disorders
|
Slater, Dennis |
|
2005 |
|
5 |
p. 418-422 5 p. |
artikel |
48 |
I-SPY 2: a new path for clinical trials
|
Schwartzberg, Lee S. |
|
2010 |
|
5 |
p. 225-227 3 p. |
artikel |
49 |
Ixabepilone: a new treatment option for resistant metastatic breast cancer
|
Cleere, Darrel W. |
|
2009 |
|
5 |
p. 219-226 8 p. |
artikel |
50 |
Lymphedema: ‘It has changed everything I do’
|
Domont, Martha |
|
2006 |
|
5 |
p. 307-308 2 p. |
artikel |
51 |
Lymphoma with effusion in an HIV patient
|
Van-Horne, Simone |
|
2005 |
|
5 |
p. 429-433 5 p. |
artikel |
52 |
Making it BIG
|
Vanchieri, Cori |
|
2005 |
|
5 |
p. 453-454 2 p. |
artikel |
53 |
Making quality care transparent with EMR
|
|
|
2007 |
|
5 |
p. 321- 1 p. |
artikel |
54 |
Managing lymphedema, a lingering problem for breast cancer patients
|
Cohen, Sara |
|
2006 |
|
5 |
p. 304-307 4 p. |
artikel |
55 |
Many groups, many factors: analysis of variance
|
Norman, Geoffrey R. |
|
2010 |
|
5 |
p. 237-239 3 p. |
artikel |
56 |
New legislation would add pay for planning services
|
Finkelstein, Joel B. |
|
2007 |
|
5 |
p. 301-302 2 p. |
artikel |
57 |
New multigene assay offers valuable insight into predicting tumor behavior
|
Babkowski, Robert C. |
|
2010 |
|
5 |
p. 200-201 2 p. |
artikel |
58 |
Occurrence of immune thrombocytopenic purpura in patients with nonhematologic cancers: a systematic review of clinical evidence from case reports
|
Tfayli, Arafat |
|
2008 |
|
5 |
p. 260-263 4 p. |
artikel |
59 |
Oncotype DX assay for predicting recurrence of stage II colon cancer
|
Abraham, Jame |
|
2010 |
|
5 |
p. 198-199 2 p. |
artikel |
60 |
One process, two perspectives
|
Curley, Brendan |
|
2012 |
|
5 |
p. 174- 1 p. |
artikel |
61 |
Our first 5 years
|
Schwartzberg, Lee S. |
|
2009 |
|
5 |
p. 191- 1 p. |
artikel |
62 |
Patients' and families' receptivity to discussions about future healthcare
|
Stearns, Lisa |
|
2005 |
|
5 |
p. 446-451 6 p. |
artikel |
63 |
Practice-hospital partnerships: a marriage made for patients
|
Leah, |
|
2008 |
|
5 |
p. 245-247 3 p. |
artikel |
64 |
Pregnancy after breast cancer
|
Alkhouri, Nabiel |
|
2007 |
|
5 |
p. 331-334 4 p. |
artikel |
65 |
Radiation therapy for cutaneous melanoma: 2008 update
|
Read, Paul W. |
|
2008 |
|
5 |
p. 236-240 5 p. |
artikel |
66 |
Rare case of renal cell carcinoma presenting as a cutaneous horn
|
Zhou, Louise |
|
2011 |
|
5 |
p. 230-232 3 p. |
artikel |
67 |
Recurrent non–small-cell lung cancer in elderly patients: a case-based review of current clinical practice
|
Ruiz, Marco |
|
2012 |
|
5 |
p. 165-170 6 p. |
artikel |
68 |
Reducing the risk of recurrence in postmenopausal women with early breast cancer: a role for aromatase inhibitors
|
Robert, Nicholas J. |
|
2006 |
|
5 |
p. 275-281 7 p. |
artikel |
69 |
Results of our EMR survey: what readers told us
|
Geffner, Edwin S. |
|
2005 |
|
5 |
p. 425-426 2 p. |
artikel |
70 |
Safeguarding patients and avoiding medical errors in chemotherapy infusion suites
|
Dohse, Linda K. |
|
2008 |
|
5 |
p. 250-252 3 p. |
artikel |
71 |
Sentinel node biopsy: a community standard
|
Spivack, Brian |
|
2008 |
|
5 |
p. 274- 1 p. |
artikel |
72 |
Spotting the time bombs in your managed care contracts
|
Fedor, Frank |
|
2005 |
|
5 |
p. 435-438 4 p. |
artikel |
73 |
Staying the course
|
Henry, David H. |
|
2008 |
|
5 |
p. 277-278 2 p. |
artikel |
74 |
Taking the team approach
|
Schwartzberg, Lee S. |
|
2006 |
|
5 |
p. 234- 1 p. |
artikel |
75 |
Telephone contacts between triage nurses and cancer patients: an integral part of a community oncology practice
|
Lucia, Victoria C. |
|
2007 |
|
5 |
p. 350-353 4 p. |
artikel |
76 |
Telephone management: a reimbursable expense?
|
Bosserman, Linda D. |
|
2007 |
|
5 |
p. 354- 1 p. |
artikel |
77 |
Testing for EGFR mutations: an emerging strategy for selecting treatment for adenocarcinoma of the lungs
|
Sequist, Lecia Van Dam |
|
2009 |
|
5 |
p. 204-206 3 p. |
artikel |
78 |
The adverse health effects of occupational exposure to hazardous drugs
|
Martin, Susan |
|
2005 |
|
5 |
p. 397-400 4 p. |
artikel |
79 |
The cancer marathon: realistic perspectives on the latest science and evolving delivery systems
|
Bosserman, Linda D. |
|
2012 |
|
5 |
p. 143-144 2 p. |
artikel |
80 |
The first FDA-approved treatment for anthracycline extravasation: bringing Totect onboard, and paying for it
|
Brutico, Carla |
|
2008 |
|
5 |
p. 231-232 2 p. |
artikel |
81 |
The high cost of low-priced cancer drugs
|
Holcombe, Dawn |
|
2005 |
|
5 |
p. 408- 1 p. |
artikel |
82 |
The House hears SGR alternatives, vows action
|
Correa, Frances |
|
2011 |
|
5 |
p. 239-240 2 p. |
artikel |
83 |
The impact of first and subsequent cycle pegfilgrastim on neutropenic events in patients receiving myelosuppressive chemotherapy in community practice: interim results of the prospective FIRST study
|
Ozer, Howard |
|
2006 |
|
5 |
p. 259-264 6 p. |
artikel |
84 |
The long path from Petri dish to patient
|
Schwartzberg, Lee S. |
|
2008 |
|
5 |
p. 218- 1 p. |
artikel |
85 |
The new era of healthcare reform
|
Schwartzberg, Lee S. |
|
2010 |
|
5 |
p. 194- 1 p. |
artikel |
86 |
The new focus on accountability
|
Klepper, Brian |
|
2006 |
|
5 |
p. 241-243 3 p. |
artikel |
87 |
The pocket-sized billing department
|
Fried, John J. |
|
2008 |
|
5 |
p. 276- 1 p. |
artikel |
88 |
There will be blood: ESA restrictions, transfusions, and cancer patients
|
Henry, David H. |
|
2008 |
|
5 |
p. 225-226 2 p. |
artikel |
89 |
The SGR by any other name…
|
Henry, David H. |
|
2011 |
|
5 |
p. 203- 1 p. |
artikel |
90 |
The value of educating patients about advance directives
|
Schapira, Lidia |
|
2005 |
|
5 |
p. 450- 1 p. |
artikel |
91 |
Three pillars of healthcare reform
|
Dawson, Milly |
|
2009 |
|
5 |
p. 237-238 2 p. |
artikel |
92 |
Totect (dexrazoxane) for treatment of anthracycline extravasation
|
Abraham, Jame |
|
2008 |
|
5 |
p. 229-230 2 p. |
artikel |
93 |
Trastuzumab in adjuvant therapy for early-stage breast cancer
|
Tucker, Steven J. |
|
2005 |
|
5 |
p. 388-390 3 p. |
artikel |
94 |
Treatment choice between GnRH receptor agonists and antagonists for advanced prostate cancer
|
Ning, Yang-Min |
|
2009 |
|
5 |
p. 200-201 2 p. |
artikel |
95 |
Triple-negative breast cancer: a clinical update
|
Cleere, Darrel W. |
|
2010 |
|
5 |
p. 203-211 9 p. |
artikel |
96 |
Understanding meta-analysis
|
Streiner, David L. |
|
2009 |
|
5 |
p. 232-235 4 p. |
artikel |
97 |
Update on paraneoplastic neurologic disorders
|
Dalmau, Josep |
|
2010 |
|
5 |
p. 219-224 6 p. |
artikel |
98 |
Update on romiplostim therapy for immune thrombocytopenic purpura
|
Stenger, Matt |
|
2011 |
|
5 |
p. 224-228 5 p. |
artikel |
99 |
Why we need a new prognostic test for colon cancer
|
Schwartzberg, Lee S. |
|
2010 |
|
5 |
p. 199-200 2 p. |
artikel |
100 |
Your open line to the CMS
|
Schwartzberg, Lee S. |
|
2005 |
|
5 |
p. 379-382 4 p. |
artikel |